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A B S T R A C T
The vitamin A value (bioefficacy) of provitamin A carotenoids is determined by absorption of the carotenoid
(bioavailability) and its subsequent conversion to retinol (bioconversion). Here we show that intestinal bio-
conversion of β-carotene can be estimated based on analysis of a single plasma sample collected 6 h after subjects
ingest a test dose of stable isotope-labeled β-carotene from the ratio of retinyl esters to retinyl esters plus β-
carotene. Plasma isotope ratio predictions of bioconversion ranged from 50 to– 93% (mean 76%) for 45 healthy
young adults with low vitamin A stores. Results were the same as predictions made by a traditional area-under-
the-curve method calculated from 0 to– 8 h or a modified area-under-the-curve method calculated from 0 to–
12 h. The modified method may provide better estimates of bioconversion between 8 and 24 h after ingestion of
a carotenoid dose when stable isotopes cannot be used due to cost or logistics. Furthermore, because the plasma
isotope ratio method requires only one blood sample and no isolation of triglyceride-rich lipoproteins, its use will
facilitate estimation of provitamin A carotenoid bioconversion in human subjects and especially children, in
whom repeated blood sampling is not feasible.
1. Introduction
Provitamin A carotenoids, especially β-carotene (βC), are a sig-
nificant source of vitamin A in the diet of many individuals worldwide,
accounting for about 70% of vitamin A intake in many lower income
areas [1,2]. Since the vitamin A value of provitamin A from different
food sources is affected by many factors [3], researchers have sought to
develop simple and accurate methods for estimating bioavailability (the
extent of carotenoid absorption), bioconversion (the extent of conver-
sion of the absorbed carotenoid to retinol), and bioefficacy (the product
of those two factors, or the proportion of ingested carotenoid that is
absorbed and converted to retinol) [4,5]; for reviews, see Refs.
[1,2,4,6].
In the current work, given that genetic variations in β-carotene
15,15′-oxygenase (BCO1) have been shown to contribute to the large
inter-individual variation observed in βC conversion efficiency [7,8],
we compared methods for estimating βC bioconversion. Previously, βC
bioconversion has been estimated based on areas under plasma con-
centration curves (AUC) for labeled βC and retinyl esters (RE) after
subjects ingest a dose of labeled βC [9–11]; estimates ranged from 35 to
88% [9,12,13]. Such AUC methods for determining bioconversion re-
quire the collection of multiple blood samples over time and frequently
include the isolation of plasma triglyceride-rich lipoproteins; each of
these considerations can limit the usefulness of the AUC method,
especially in children in whom repeated blood sampling is difficult.
Recently [14], we validated the use of a plasma retinol isotope ratio
method for estimating carotenoid relative bioefficacy based on analysis
of a single blood sample obtained after previously-studied subjects
[15,16] consumed a dose of labeled βC and a reference dose of labeled
retinyl acetate. Here we extend that method to estimate intestinal βC
bioconversion, showing that one obtains comparable results from a
plasma isotope ratio (IR) and two AUC methods. We also present a
correction method to improve predictions of bioconversion estimated
by the traditional AUC method. Use of the single-sample, whole plasma
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method to estimate intestinal βC bioconversion will allow this para-
meter to be more easily determined in human subjects, including
children.
2. Methods
2.1. Subjects and data collection
We used data from 45 individuals previously described by Oxley
et al. [15]; see also Green et al. [16]. In brief, after an overnight fast,
healthy young men and women received doses of [13C10]retinyl acetate
(1 mg) and [13C10]βC (2mg) in sunflower oil via an oral syringe. They
then consumed a breakfast meal that contained 46 g fat, 64 g carbo-
hydrate and 10 g protein (717 kcal). Four h later, participants had a
lunch meal that contained 37 g fat, 63 g carbohydrate and 18 g protein
(655 kcal); a dinner meal consumed 8 h after dose administration pro-
vided 20 g fat, 43 g carbohydrate and 18 g protein (440 kcal); water was
the only beverage offered on d 1. After the first day of the study, sub-
jects were asked not to deviate from their habitual diets. All procedures
involving human subjects were approved by the National Research
Ethics Service, North East–Sunderland Committee (REC 09/H0904/20)
and the study was registered with the UK Clinical Research Network
(UKCRN: 7413).
Ten blood samples were collected from each subject from 2 h to 14 d
after dose administration; for the current work, we used data for sam-
ples obtained from 2 to 24 h (2, 4, 6, 8, 10, 12 and 24 h; n=7). Plasma
was analyzed by LC-MS/MS for [13C10]RE and [13C10]retinol derived
from the retinyl acetate dose and for [13C10]βC, [13C5]RE and [13C5]
retinol derived from the βC dose [15]. For the current analysis, we
examined data for [13C10]βC and for the [13C5]RE derived from
[13C10]βC.
2.2. Estimation of intestinal bioconversion of β-carotene
For each subject, plasma concentration of labeled RE (μmol/L) was
converted to molar βC equivalents (REβCe). That is, because 1 molecule
of all-trans-βC could maximally yield 2 molecules of retinol, we calcu-
lated [13C5]REβCe as [13C5]RE/2. Plasma concentrations (μmol/L) of
labeled βC and labeled REβCe were plotted versus time after dose ad-
ministration. Then, intestinal bioconversion of absorbed βC was cal-
culated at 2, 4, 6, 8, 10, 12 and 24 h after dosing as a plasma isotope
ratio (IR method): {[13C5]REβCe/([13C5]REβCe + [13C10]βC)}× 100.
In addition to the IR method, intestinal bioconversion of absorbed
βC was calculated using a traditional AUC method as {AUC for [13C5]
REβCe/(AUC for [13C5]REβCe + AUC for [13C10]βC)}× 100, where
areas under the plasma isotope response curves [(μmol/L)× h] were
integrated from 0 to 2, 4, 6, 8, 10, 12 or 24 h. Also, we developed an
adjusted AUC method (AUCadj) that corrects for βC in very low density
lipoproteins (VLDL) because at later times, labeled βC in plasma will be
transported not only in chylomicrons but also in VLDL secreted by the
liver. The rationale for the AUCadj method is that incorporation of βC
and RE into nascent chylomicrons is linked [17,18] and if we assume
that the ratio of βC to RE in chylomicrons remains relatively constant,
we can use labeled RE as a proxy for chylomicron βC. For the AUCadj
method, we calculated chylomicron βC concentrations as [13C10]βC at
6 h× {[13C5]RE at 8, 10, 12 or 24 h/[13C5]RE at 6 h}, assuming that at
6 h, labeled βC was primarily in chylomicrons and any contribution
from VLDL would be minimal (i.e., VLDL βC at 6 h=0 and total βC
concentration at 6 h= chylomicron βC concentration at 6 h). Specifi-
cally, we calculated ratios for [13C5]RE concentration at 8, 10, 12 and
24 h versus [13C5]RE at 6 h for each subject (see Results); the ratios at
these times were then multiplied by individual subject values for
[13C10]βC concentration at 6 h to derive estimated chylomicron βC
concentrations from 8 to 24 h.
Then, estimated βC chylomicron concentrations were used to cal-
culate intestinal bioconversion as {AUC for [13C5]REβCe/(AUC for
[13C5]REβCe + AUC for chylomicron [13C10]βC)}× 100.
Estimates of intestinal bioconversion predicted by the IR method
and the two AUC methods were compared graphically and statistically
as described later.
2.3. Data manipulations and statistics
Data are presented as means ± SD (range) or as means ± SEM.
Areas under plasma isotope response curves were integrated by appli-
cation of the trapezoidal rule using GraphPad Prism v. 7.0 (GraphPad
Software Inc.). Figures and data simulations were also done using
GraphPad Prism v. 7.0. Predictions of intestinal bioconversion by the IR
and AUC methods were compared using mixed models ANOVA (with
‘method’, ‘time’ and ‘method× time’ as fixed effects, and ‘subject’,
‘subject×method’ and ‘subject× time’ as random effects) and two
post-hoc tests: the Tukey honest significant difference test to determine
within-subject differences and the two one-sided tests approach to test
equivalence using a threshold of 3 bioconversion percentage units (JMP
Pro v. 13; SAS Institute Inc.) for the 6 h IR versus 8 h AUC comparison.
P < 0.05 was considered significant. Least squares regression analysis
was performed using GraphPad Prism v. 7.0.
3. Results and discussion
3.1. Subject characteristics
Among the 45 healthy subjects, 25 were female and 20 were male;
the mean age was 24 ± 4 y and body mass index was 22 ± 2.2 kg/m2;
plasma retinol concentrations were within the normal range
(1.51 ± 0.28 μmol/L). Vitamin A total body stores, estimated for 30 of
the subjects studied previously using model-based compartmental
analysis [16], averaged 123 ± 71 μmol.
3.2. Plasma tracer kinetics
Mean plasma concentrations versus time for [13C10]βC and for
[13C5]REβCe derived from the βC dose are shown in Fig. 1A. The data
indicate that labeled βC increased from 2 to 6 h after dose ingestion,
decreased from 6 to 8 h, and then further increased after 8 h; in con-
trast, labeled REβCe peaked at 6 h and then decreased with time. Similar
plots, as well as data for the sum of the two tracers (i.e., [13C10]βC plus
[13C5]REβCe, with retinyl esters expressed as molar β-carotene equiva-
lents), are shown in Fig. 1B for a subject with high intestinal bio-
conversion (85%) based on the 8 h AUC method (see next section) and
in Fig. 1C for an individual with a lower bioconversion (55%). Note that
the curves for the sum of the two tracers reflect absorption of labeled
βC. For the individual shown in Fig. 1B, labeled βC followed a time
course that was similar to the pattern for the group mean data (Fig. 1A);
in contrast, the peak at 6 h for labeled REβCe was higher than the group
mean (0.24 μmol/L versus 0.035 μmol/L) and then REβCe decreased
dramatically with time. For the subject shown in Fig. 1C, the labeled βC
response was similar to the group mean response and labeled REβCe
peaked at 6 h (0.039 μmol/L). However, the overall REβCe response for
this subject was much lower than for the individual with higher in-
testinal bioconversion (Fig. 1B) and for the group mean data (Fig. 1A).
For the subject shown in Fig. 1B, total plasma concentration of label (βC
plus REβCe) peaked at 0.28 μmol/L, compared with 0.069 μmol/L for
the subject with the lower intestinal bioconversion (Fig. 1C), pre-
sumably reflecting a higher βC absorption (i.e., bioavailability). As
shown in Fig. 2, for the vast majority of subjects (38 of the 45), the
maximum concentration of plasma labeled REβCe was observed at 4 h
(n= 16) or 6 h (n=22) post-dosing; for 3 subjects, the maximum was
seen at 8 h, and for 4 subjects, it was at 10 h.
Although in most subjects, plasma REβCe decreased continuously
after the early peak, in a some subjects (n=10), there was a second
peak in REβCe at 10 h; for 3 of these 10 subjects, the maximum
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concentration of REβCe in plasma was observed at the second (10 h)
peak (Fig. 2). The initial, predominant peak (at 6 or 8 h) in a given
subject is likely the response to the breakfast and lunch meals (con-
sumed after dose administration and after collection of the 4 h blood
sample, respectively), whereas when a second peak was observed at
10 h, it is likely an additional response to the dinner meal (consumed
after the 8 h sample was collected).
3.3. Intestinal β-carotene bioconversion
A summary of the results for intestinal βC bioconversion predicted
by IR and AUC is presented in Table 1. Note that results for IR versus
AUC are the same at 2 h because only one sample was collected by this
time and thus the same data were used for both calculations. Since the
plasma concentration of REβCe was highest relative to βC at 2 h after
dosing, the data indicate that bioconversion was most efficient in these
subjects at this time. In fact, for all volunteers, [13C5]RE was detected in
the 2 h plasma sample, whereas [13C10]βC was not detected in plasma
for 10 of the 45 subjects at 2 h and for one even at 4 h. By 6 h, both
labeled βC and its RE metabolite were detected in plasma of all subjects.
In the case of the IR method (Table 1), mean predictions were
highest at 2 h (87%) and then decreased to 63% at 8 h; the two sub-
sequent values were substantially lower at each time, reaching 10% at
24 h. In contrast, for the traditional AUC method (column 3), the in-
itially high value at 2 h gradually decreased to 68% at 12 h; by 24 h, the
prediction was substantially lower (46%). When comparing the IR and
AUC methods, mean predictions were not significantly different at 4
and 6 h. At times from 8 h on, IR predictions of bioconversion were
significantly lower than those calculated by AUC. For the AUC method,
we used 8 h as a basis for comparison to the IR since past studies were
carried out only until 8 [9] or 9 h after dosing [10]. In addition, up to
8 h, the influence of incoming VLDL βC on area calculations for βC and
thus on bioconversion is less than at later times (see next paragraph).
Compared to mean predictions by the AUC method at 8 h (76%), mean
predictions by the IR at 4 h (79%) and 6 h (76%) were not significantly
different from each other or from the AUC result at 8 h. However, va-
lues predicted by the IR at 6 h were closer to values calculated by the
AUC at 8 h and in fact, based on the two one-sided tests, the means were
practically equivalent (to within our threshold of 3 bioconversion units;
P= 0.0054); the mean ratio of IR at 6 h/AUC at 8 h was 1.0 (range,
0.80–1.1). As shown in Fig. 3A, individual subject predictions by the IR
at 6 h were strongly and significantly correlated with values calculated
using the AUC method at 8 h (R2= 0.91; P < 0.0001). When predic-
tions were ranked (Fig. 3B), we found a strong and significant rank-
order correlation (R= 0.96, P < 0.0001). Since, in the field, one
would not know the time at which plasma RE peaks in a given subject,
we compared predictions by the IR at 6 h and the AUC at 8 h for subjects
sorted by the time that a first peak in RE was observed (4, 6, 8 or 10 h)
(Fig. 2). Overall, for subjects in whom the peak was observed at 4, 6 or
8 h, the mean ratio of 6 h IR/8 h AUC was within 3 bioconversion
percentage units. The first RE peak was observed at 10 h for only 1
subject (i.e., for the other 3 subjects in whom a 10 h peak was observed,
it was a second peak); in that subject, the ratio of 6 h IR/8 h AUC was
1.1. Based on these results, we suggest that 6 h may be an optimal time
to use the IR method to predict intestinal bioconversion.
The decreases we observed in intestinal βC bioconversion over time
are compatible with current understanding of the formation and me-
tabolism of triglyceride-rich lipoproteins. Specifically, the initial de-
crease (2 to 6 h) is likely explained by a delay in the incorporation of βC
versus βC-derived retinyl esters into chylomicrons [9]; by 8 h, the
Fig. 1. Observed data for concentration of tracers in plasma versus time. Shown
are group mean μmol/L ± SEM (n=45) for [13C10]βC (circles connected by a
solid line) and for [13C5]REβCe (squares connected by a dashed line) (panel A).
Arrows indicate when lunch and dinner were provided. Also shown are μmol/L
versus time for [13C10]βC (circles connected by a solid line), for [13C5]REβCe
derived from the βC dose (squares connected by a dashed line), and for the sum
of these tracers (reflecting total absorbed [13C10]βC; triangles and dotted lines)
for subjects with high (85%; panel B) and low intestinal bioconversion (55%;
panel C). Panel C inset shows tracer concentrations to 14 h for the subject with
low bioconversion. Subjects whose data are illustrated in panels B and C were
selected based on bioconversion calculated by AUC using data from 0 to -8 h.
AUC, area under the curve; βC, β-carotene; REβCe, retinyl esters as molar β-
carotene equivalents.
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continuing decrease is likely due to appearance of labeled βC in VLDL
[19]. Presumably, predictions by the plasma IR method after 6 h de-
creased at a faster rate compared with AUC because VLDL appearance
in plasma will have a greater effect on the ratio at any single time
compared with its impact on the cumulative area used to calculate AUC.
In addition, note that the IR method at 6 h predicts bioconversion of βC
to RE during absorption of components of the breakfast meal and the
early post-prandial response to the lunch consumed after collection of
the 4 h blood sample.
Since it is known that, at early times after administration of labeled
carotenoid, βC in plasma is found exclusively in chylomicrons but at
later times, it is also present in VLDL, we estimated the likely time
course for the labels in chylomicrons versus VLDL as a fraction of the
total βC concentration. As shown in Fig. 4, simulations indicate that
mean βC in chylomicrons peaked by 6 h after dosing and that by 8 h, βC
was also present in VLDL; by 10 h, βC in VLDL slightly exceeded βC in
chylomicrons. At 12 h, most of the labeled βC appeared to be
transported in VLDL and even more so by 24 h.
As stated earlier, we also calculated intestinal βC bioconversion
using estimated chylomicron βC concentrations for the adjusted AUC
method. For this method, we determined that mean (± SD) [13C5]
REβCe concentrations at 8, 10, 12 and 24 h relative to those at 6 h were
66 ± 48% (8 h), 67 ± 85% (10 h), 34 ± 34% (12 h) and 6.7 ± 8%
(24 h); then [13C10]βC concentrations at 6 h for each subject were
multiplied by their fractional change in REβCe at these times to estimate
βC concentrations in chylomicrons at 8, 10, 12 and 24 h. Predictions of
bioconversion calculated using the AUCadj method stabilized and were
relatively constant from 8 to 24 h (Table 1). In addition, as also shown
in the table, if total βC is corrected for βC in VLDL, mean AUC pre-
dictions at 8 h and IR predictions at 6 h agree with AUCadj predictions
from 8 to 24 h. When we compared values predicted by the IR at 6 h to
values calculated by the AUCadj at 12 h, the mean ratio of IR at 6 h/
AUCadj at 12 h was 0.98 (range, 0.81–1.0). As shown in Fig. 3C, in-
dividual subject predictions by the IR at 6 h were strongly and
Fig. 2. Observed data for plasma tracer concentrations versus time. Shown are mean μmol/L ± SEM for [13C10]βC (circles connected by a solid line) and for [13C5]
REβCe (squares connected by a dashed line) for subjects with the highest RE concentrations at 4 (n=16), 6 (n= 22), 8 (n=3) or 10 (n= 4) h (panels A–D,
respectively). βC, β-carotene; REβCe, retinyl esters as molar β-carotene equivalents.
Table 1
Intestinal βC bioconversion estimated by an IR and two AUC methodsA.
Time (h) IR (%) AUC (%) AUCadjB (%)
2 87.2 ± 10.2 (60.0–100.0) 87.2 ± 10.2 (60.0–100.0) 87.2 ± 10.2 (60.0–100.0)
4 79.0 ± 11.0abc (50.3–100.0) 81.7 ± 8.9ab (58.4–100.0) 81.7 ± 8.9a (58.4–100.0)
6 76.0 ± 11.1cd (49.9–92.6) 78.8 ± 9.3abc (57.5–91.3) 78.8 ± 9.3abc (57.5–91.3)
8 63.4 ± 15.6f (34.6–84.2) 76.2 ± 9.9c (55.3–88.8) 78.0 ± 9.7bc (57.4–92.0)
10 52.4 ± 16.1g (21.9–80.4) 72.2 ± 10.8d (50.7–86.0) 77.7 ± 9.8c (57.4–92.4)
12 38.5 ± 14.0i (10.0–62.3) 67.8 ± 11.7e (45.8–83.7) 77.5 ± 9.9c (57.3–92.5)
24 9.5 ± 5.3j (0.93–28.9) 45.8 ± 13.1h (21.9–70.0) 77.2 ± 10.1c (57.3–92.6)
AValues are means ± SD (range) for percent intestinal β-carotene bioconversion predicted using a plasma isotope ratio method compared to two area-under-the-
curve methods (n= 45 at each time). BAUC for intestinal βC bioconversion calculated using the estimated chylomicron βC concentrations that were corrected for
very low density lipoprotein βC; see text for details. Means with different superscript letters are significantly different (P < 0.05) based on the significant
‘method× time’ interaction determined by mixed models ANOVA. Note that predictions at 2 h were identical for the 3 methods and thus were excluded from the
mixed model analysis. AUC, area under the curve; AUCadj, adjusted AUC; βC, β-carotene; IR, isotope ratio.
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significantly correlated with values calculated using the AUCadj method
at 12 h (R2=0.95; P < 0.0001). When ranked (Fig. 3D), predictions
were strongly and significantly correlated (R=0.98, P < 0.0001).
These results further support the use of the IR at 6 h to predict intestinal
bioconversion.
Previous researchers have reported that βC bioconversion ranged
from 35 to 88% [9,12,13]; our current 6 h IR predictions range from 50
to– 93% (mean, 76%). This relatively high bioconversion may relate to
the low vitamin A total body stores in these subjects (123 μmol for 30 of
the 45 individuals studied by Green et al. [16]). In addition, as pre-
viously reported [20,21], the efficiency of βC absorption and its con-
version to retinol (i.e., bioefficacy) is highly variable among in-
dividuals. For the current subjects, the coefficient of variation (CV) for
intestinal βC bioconversion predicted by the 6 h IR was 14%. As found
in the earlier study by Green et al. [16], in which relative bioefficacy
was estimated for 30 of these 45 subjects, the CV for that parameter was
44%. Taken together, these results suggest that the large inter-in-
dividual variation in bioefficacy is more likely due to high variability in
the absorption of βC (i.e., bioavailability) rather than in its conversion
efficiency.
3.4. Concluding comments
In view of current results for the plasma isotope ratio method for
estimating intestinal βC bioconversion, it would be worthwhile to apply
the IR and the adjusted AUC method retrospectively to previously-
collected data from studies that have used AUC methods and to com-
pare results obtained by the three methods. One limitation of both the
IR and AUC methods to estimate intestinal bioconversion of carotenoids
is that there is no “reference method” that can be used to validate the
results. We suggest that, in subsequent work, researchers could apply
the tools of model-based compartmental analysis of theoretical data to
generate “known values” for bioavailability and bioconversion that
could be compared with IR and AUC calculations done on the same
data. We [14] recently used such a strategy to validate a plasma retinol
isotope ratio method for estimating βC bioefficacy at 14 or more days
after dosing with labeled βC and retinyl acetate (reference dose).
In conclusion, we have shown that the ratio of plasma concentration
Fig. 3. Bioconversion estimated by an IR method and two AUC methods. Intestinal βC bioconversion calculated by the IR at 6 h versus AUC at 8 h is shown in panel A;
IR at 6 h versus AUCadj at 12 h is presented in panel C; n=45. See text for methods of calculation. Least squares regression lines were y= 1.0x – 3.2 (R2= 0.91;
P < 0.0001) (panel A) and y=1.0x – 0.62 (R2=0.95; P < 0.0001) (panel C). Rank-order correlations are shown in panel B for AUC (R=0.96, P < 0.0001) and
in panel D for AUCadj (R= 0.98, P < 0.0001). AUC, area under the curve; AUCadj, adjusted AUC; βC, β-carotene; IR, isotope ratio.
J.L. Ford et al. Archives of Biochemistry and Biophysics 653 (2018) 121–126
125
in retinyl esters to that in retinyl esters plus β-carotene in a single
plasma sample collected 6 h after subjects ingest a test dose of labeled
β-carotene provides an estimate of intestinal bioconversion of β-car-
otene that is comparable to area-under-the-curve estimates which re-
quire analysis of multiple blood samples. The ability to estimate bio-
conversion based on analysis of a single sample of whole plasma will
make it feasible to measure intestinal β-carotene bioconversion in
human subjects, and especially in children.
Author disclosure statement
The authors declare no competing financial interests.
Abbreviations used
AUC, area under the curve; AUCadj, adjusted AUC; βC, β-carotene;
IR, isotope ratio; RE, retinyl esters; REβCe, retinyl esters as molar β-
carotene equivalents; VLDL, very low density lipoproteins.
Acknowledgment
Experimental studies were conducted at Newcastle University with
support from the Biotechnology and Biological Science Research
Council, United Kingdom (grant BB/G004056/1). The work presented
here was partially supported by the College of Health and Human
Development, The Pennsylvania State University.
References
[1] G. Tang, Bioconversion of dietary provitamin A carotenoids to vitamin A in humans,
Am. J. Clin. Nutr. 91 (5) (2010) 1468S–1473S.
[2] M.J. Haskell, The challenge to reach nutritional adequacy for vitamin A: β-carotene
bioavailability and conversion – evidence in humans, Am. J. Clin. Nutr. 96 (suppl)
(2012) 1193S–1203S.
[3] J.J.M. Castenmiller, C.E. West, Bioavailability and bioconversion of carotenoids,
Annu. Rev. Nutr. 18 (1998) 19–38.
[4] M. van Lieshout, C.E. West, R.B. van Breemen, Isotopic tracer techniques for
studying the bioavailability and bioefficacy of dietary carotenoids, particularly β-
carotene, in humans: a review, Am. J. Clin. Nutr. 77 (1) (2003) 12–28.
[5] C.A. Van Loo-Bouwman, T.H.J. Naber, G. Schaafsma, A review of vitamin A
equivalency of β-carotene in various food matrices for human consumption, Br. J.
Nutr. 111 (2014) 2153–2166.
[6] K.J. Yeum, R.M. Russell, Carotenoid bioavailability and bioconversion, Annu. Rev.
Nutr. 22 (2002) 483–504.
[7] W.C. Leung, S. Hessel, C. Méplan, J. Flint, V. Oberhauser, F. Tourniaire,
J.E. Hesketh, J. von Lintig, G. Lietz, Two common single nucleotide polymorphisms
in the gene encoding β-carotene 15,15'-monoxygenase alter β-carotene metabolism
in female volunteers, FASEB J. 23 (4) (2009) 1041–1053.
[8] G. Lietz, A. Oxley, W. Leung, J. Hesketh, Single nucleotide polymorphisms upstream
from the β-carotene 15,15'-monoxygenase gene influence provitamin A conversion
efficiency in female volunteers, J. Nutr. 142 (1) (2012) 161S–165S.
[9] T. van Vliet, W.H. Schreurs, H. van den Berg, Intestinal beta-carotene absorption
and cleavage in men: response of beta-carotene and retinyl esters in the triglyceride-
rich lipoprotein fraction after a single oral dose of beta-carotene, Am. J. Clin. Nutr.
62 (1) (1995) 110–116.
[10] M.K. Fleshman, K.M. Riedl, J.A. Novotny, S.J. Schwartz, E.H. Harrison, An LC/MS
method for d8-β-carotene and d4-retinyl esters: β-carotene absorption and its
conversion to vitamin A in humans, J. Lipid Res. 53 (4) (2012) 820–827.
[11] R.E. Kopec, J.L. Cooperstone, R.M. Schweiggert, G.S. Young, E.H. Harrison,
D.M. Francis, S.K. Clinton, S.J. Schwartz, Avocado consumption enhances human
postprandial provitamin A absorption and conversion from a novel high-β-carotene
tomato sauce and from carrots, J. Nutr. 144 (8) (2014) 1158–1166.
[12] D.S. Goodman, R. Blomstrand, B. Werner, H.S. Huang, T. Shiratori, The intestinal
absorption and metabolism of vitamin A and β-carotene in man, J. Clin. Invest. 45
(10) (1966) 1615–1623.
[13] R. Blomstrand, B. Werner, Studies on the intestinal absorption of radioactive β-
carotene and vitamin A in man: conversion of β-carotene into vitamin A, Scand. J.
Clin. Lab. Invest. 19 (4) (1967) 339–345.
[14] J.L. Ford, J.B. Green, G. Lietz, A. Oxley, M.H. Green, A simple plasma retinol iso-
tope ratio method for estimating β-carotene relative bioefficacy in humans is va-
lidated using model-based compartmental analysis, J. Nutr. 147 (9) (2017)
1806–1814.
[15] A. Oxley, P. Berry, G.A. Taylor, J. Cowell, M.J. Hall, J. Hesketh, G. Lietz,
A.V. Boddy, An LC/MS/MS method for stable isotope dilution studies of β-carotene
bioavailability, bioconversion, and vitamin A status in humans, J. Lipid Res. 55 (2)
(2014) 319–328.
[16] M.H. Green, J.L. Ford, A. Oxley, J.B. Green, H. Park, P. Berry, A.V. Boddy, G. Lietz,
Plasma retinol kinetics and β-carotene bioefficacy are quantified by model-based
compartmental analysis in healthy young adults with low vitamin A stores, J. Nutr.
146 (10) (2016) 2129–2136.
[17] H.C. Furr, R.M. Clark, Intestinal absorption and tissue distribution of carotenoids, J.
Nutr. Biochem. 8 (7) (1997) 364–377.
[18] M.M. Hussain, A proposed model for the assembly of chylomicrons, Atherosclerosis
148 (1) (2000) 1–15.
[19] E.J. Johnson, R.M. Russell, Distribution of orally administered β-carotene among
lipoproteins in healthy men, Am. J. Clin. Nutr. 56 (1) (1992) 128–135.
[20] S.J. Hickenbottom, J.R. Follett, Y. Lin, S.R. Dueker, B.J. Burri, T.R. Neidlinger,
A.J. Clifford, Variability in conversion of β-carotene to vitamin A in men as mea-
sured by using a double-tracer study design, Am. J. Clin. Nutr. 75 (5) (2002)
900–907.
[21] Y. Lin, S.R. Dueker, B.J. Burri, T.R. Neidlinger, A.J. Clifford, Variability of the
conversion of β-carotene to vitamin A in women measured by using a double-tracer
study design, Am. J. Clin. Nutr. 71 (6) (2000) 1545–1554.
Fig. 4. Observed and estimated data for concentration of tracers in plasma
versus time. Shown are group mean ± SEM (n=45) observed μmol/L for
[13C10]βC (circles and solid line) and simulated data for βC in chylomicrons
(squares and dashed line) versus VLDL (triangles and dotted line). Arrows in-
dicate when lunch and dinner were provided. βC, β-carotene; VLDL, very low
density lipoproteins.
J.L. Ford et al. Archives of Biochemistry and Biophysics 653 (2018) 121–126
126
